Robinson Pharma Expands Costa Mesa, California, Operations
09/17/2019
According to company officials, this new addition brings Robinson Pharma to now six buildings and totaling over 650,000 square feet. The new state-of-the-art eco-friendly facility will serve as RPI’s newest expansion to accommodate its continuing business growth.
The building spans 100,276 square feet and sits on more than five acres of land. RPI has committed to invest $20M in this facility to better serve its customers with the latest advances in nutraceutical contract manufacturing and quality assurance.
With these new investments, RPI said it will keep pace with the growing demand for wellness products and continue in its vision to provide the best in service in the supplement industry.
Robinson Pharma, Inc., is a Southern California-based full-service contract manufacturer of dietary supplements with over 650,000 square feet of production capabilities of capsules, softgels, tablets, powders, and liquids. Robinson Pharma, Inc. possesses multiple third-party certifications of current Good Manufacturing Practice (cGMP) and Safe Quality Food (SQF) compliance from well-reputed organizations, such as Eurofins, NPA, NSF, and UL for supplement manufacturing in the United States.
Most Read
-
-
Life Sciences Fueling Construction Demand
Q2 2021
-
2020 Top States for Doing Business Showcase Their Pro-Business Environments
Q3 2020
-
A Turnkey Approach to Manufacturing Location Decisions
Q2 2021
-
35th Annual Corporate Survey: Effects of Global Pandemic Reflected in Executives’ Site and Facility Plans
Q1 2021
-
What’s Driving Record Industrial Real Estate Demand
Q1 2021
-
Challenges of Moving Manufacturing Out of China
Q1 2021